200.77USD-1.19%Mkt Cap: 28.46B USDP/E: —Last update: 2026-05-26
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence mon…
Industry Peers
Diagnostics & Research166.94BUSDP/E 24.7
122.72BUSDP/E 33.6
44.05BUSDP/E 41.1
34.42BCHFP/E 37.9
33.46BUSDP/E 43.3
32.69BUSDP/E 25.5
27.28BUSDP/E 20.3
22.36BUSDP/E 26.0
Indicators:|
Key Statistics
Company
Market Cap28.46B USD
Enterprise Value28.32B USD
Revenue (TTM)2.50B USD
Gross Profit1.49B USD
Net Income (TTM)-208.16M USD
Revenue/Share18.07 USD
Last Price200.77 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6.1K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-538.69
PEG—
EV/EBITDA-105.85
EV/Revenue11.33
P/S11.66
P/B16.62
EPS (TTM)-1.63
EPS (Forward)-0.38
52W Range
131.8155% of range256.36
52W High256.36 USD
52W Low131.81 USD
Profitability
Gross Margin64.75%
Oper. Margin-12.39%
EBITDA Margin-10.70%
Profit Margin-9.03%
ROE-12.16%
ROA-8.68%
Growth
Revenue Growth38.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF215.30M USD
CapEx (TTM)139.19M USD
FCF Margin5.47%
FCF Yield0.48%
Net Debt-847.85M USD
Net Debt/EBITDA3.17
Balance Sheet
Debt/Equity0.13
Current Ratio2.96
Quick Ratio2.70
Book Value/Sh12.26 USD
Cash/Share7.596 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)260.89 USD
Target Range193.00 USD – 300.00 USD
# Analysts18
Ownership
Shares Out.143.22M
Float138.88M
Insiders3.02%
Institutions95.87%
Short Interest
Short Ratio3.1d
Short % Float2.90%
Short % Out.2.82%
Shares Short4.02M
Short (prev mo.)4.87M
Technical
SMA 50201.06 (-0.1%)
SMA 200201.22 (-0.2%)
Beta1.57
S&P 52W Chg28.31%
Avg Vol (30d)1.53M
Avg Vol (10d)1.92M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—